A Randomized Trial of Punctuated Antiretroviral Therapy in Ugandan HIV-Seropositive Adults With Pulmonary Tuberculosis and CD4⁺ T-Cell Counts of ≥350 cells/µL

Background. Optimal treatment of human immunodeficiency virus (HlV)-associated tuberculosis in patients with high CD4⁺ T-cell counts is unknown. Suppression of viral replication during therapy for tuberculosis may block effects of immune activation on T cells and slow HIV disease progression. Method...

Full description

Bibliographic Details

Published in:	The Journal of infectious diseases Vol. 204; no. 6; pp. 884 - 892
Main Authors:	Nanteza, M. W., Mayanja-Kizza, H., Charlebois, E., Srikantiah, P., Lin, R., Mupere, E., Mugyenyi, P., Boom, W. H., Mugerwa, R. D., Havlir, D. V., Whalen, C. C.
Format:	Journal Article
Language:	English
Published:	Oxford University Press 15-09-2011
Subjects:	AIDS Antiretrovirals Health outcomes HIV HIV/AIDS Mycobacterium tuberculosis Pulmonary tuberculosis Research universities RNA T lymphocytes Tuberculosis
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!